4th Quarter - Report
BOCKORNY GROUP, INC. for ABBOTT LABORATORIES
Firm
Client
Income
$70,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of the Patient Protection and Affordable Health Care Act H.R. 3497 - Moddern Cures Act of 2011 H.R. 6446, To create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOCKORNY | — |
| MELISSA SCHULMAN | — |
| PAUL SCOTT SHEARER | — |
| NICOLE VENABLE | — |
Trade (domestic/foreign) TRD
Global health and development U.S. Negotiations on Trans Pacific Partnership H.R. 6156, Russia and Moldova Jackson-Vanik Repeal Act of 2012
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE VENABLE | — |
Taxation/Internal Revenue Code TAX
Corporate Tax Reform Proposals
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOCKORNY | — |
| MELISSA SCHULMAN | — |
| PAUL SCOTT SHEARER | — |
| NICOLE VENABLE | — |
Medicare/Medicaid MMM
Medicare Part D drug benefit
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOCKORNY | — |
| MELISSA SCHULMAN | — |
| PAUL SCOTT SHEARER | — |
| NICOLE VENABLE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.